, ATI PN Comprehensive Exam Bank: 250 Questions &
Answers (2026/2027 Update) - Chamberlain University
ATI PN Comprehensive Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest NCSBN Guidelines | Graded A+
This comprehensive exam bank contains 250 verified questions and answers designed to prepare
nursing students for the ATI PN (Practical Nurse) exam. Covering all major content areas, this resource
reflects the latest 2026/2027 updates and NCSBN guidelines. Each question includes detailed
rationales and correct answers to enhance understanding and retention. Ideal for Chamberlain
University students seeking a reliable study tool for achieving a high score.
Key Features:
Pharmacological Therapies and Dosage Calculations
Safe and Effective Care Environment (Management, Safety, Infection Control)
Health Promotion and Maintenance (Growth, Development, Prevention)
Psychosocial Integrity (Coping, Mental Health, Therapeutic Communication)
Physiological Integrity (Basic Care, Comfort, Reduction of Risk Potential)
Updates for 2026:
- Updated to reflect 2026/2027 NCSBN PN test plan changes
- Revised rationales for clarity and evidence-based practice
- Added new questions on emerging healthcare topics (e.g., telehealth, COVID-19 management)
- Enhanced distractor explanations to address common misconceptions
Abstract:
The ATI PN Comprehensive Exam Bank is a meticulously curated collection of 250 questions and answers aligned
with the 2026/2027 NCSBN PN test plan. Designed for Chamberlain University nursing students, this resource
covers all core content areas: pharmacological therapies, safe and effective care environment, health promotion,
psychosocial integrity, and physiological integrity. Each question is accompanied by a detailed rationale
explaining the correct answer and why distractors are incorrect, promoting deep learning and critical thinking.
The bank has been updated to include recent healthcare trends and evidence-based practices, ensuring relevance
to current clinical settings. This exam prep tool is ideal for self-assessment, identifying knowledge gaps, and
building confidence for the ATI PN exam. With a focus on high-yield topics and graded A+ standards, it serves as
a comprehensive study guide for achieving exam success.
Keywords:
ATI PN exam, practical nurse, NCLEX-PN, NCSBN, Chamberlain University, exam bank, nursing questions,
rationales
Answer Format:
Each question is followed by the correct answer (marked as 'Correct Answer:') and a detailed rationale explaining
why it is correct. Incorrect options are also explained with distractors to clarify common errors. Rationales are
concise yet comprehensive, referencing evidence-based practice and NCSBN guidelines.
Compliance Checklist:
Aligned with 2026/2027 NCSBN PN test plan
Updated per latest clinical guidelines and evidence-based practice
All questions verified for accuracy by nursing educators
Includes rationales for correct and incorrect answers
Suitable for self-study and exam simulation
Page 1
,Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacological Therapies 1-50 Dosage calculations, medication 20%
administration, adverse effects,
pharmacokinetics
Safe and Effective Care 51-100 Management of care, safety and infection 20%
Environment control, legal/ethical issues, emergency
preparedness
Health Promotion and 101-150 Growth and development, disease 20%
Maintenance prevention, prenatal/postpartum care, health
screening
Psychosocial Integrity 151-200 Coping mechanisms, mental health 20%
disorders, therapeutic communication,
cultural awareness
Physiological Integrity 201-250 Basic care and comfort, reduction of risk 20%
potential, physiological adaptation,
fluid/electrolyte balance
Page 2
, Q1. A client with a history of chronic kidney disease (CKD) stage 4 is admitted with hyperkalemia (serum
potassium 6.8 mEq/L). The provider orders intravenous calcium gluconate, regular insulin with dextrose
50%, and sodium polystyrene sulfonate (Kayexalate). Which of the following best explains the mechanism of
action of the insulin-dextrose combination in this context?
A. Insulin binds to potassium ions, forming an inactive complex that is renally excreted.
B. Insulin stimulates the sodium-potassium ATPase pump, promoting intracellular shift of potassium.
C. Dextrose provides a substrate for insulin to facilitate potassium excretion via the gastrointestinal tract.
D. Insulin increases aldosterone secretion, leading to potassium loss in the urine.
Correct Answer: B. Insulin stimulates the sodium-potassium ATPase pump, promoting intracellular shift of
potassium.
Rationale: Insulin activates the sodium-potassium ATPase pump, which moves potassium from the extracellular
fluid into cells, thereby lowering serum potassium. This effect is rapid and temporary, used in acute hyperkalemia.
Dextrose prevents hypoglycemia caused by insulin. Option A is incorrect because insulin does not bind potassium.
Option C is incorrect because insulin-dextrose does not promote GI excretion. Option D is incorrect because
insulin does not increase aldosterone secretion.
Why Wrong:
A - Insulin does not chemically bind potassium; it facilitates cellular uptake via pump activation.
C - The combination does not enhance GI potassium excretion; that is the role of sodium polystyrene
sulfonate.
D - Insulin has no direct effect on aldosterone; aldosterone increases renal potassium excretion, not cellular
shift.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 50: Agents for Hyperkalemia.
Q2. A client with type 2 diabetes mellitus is prescribed metformin 500 mg twice daily. Which of the following
best describes the primary mechanism by which metformin improves glycemic control?
A. Stimulates pancreatic beta cells to secrete more insulin.
B. Increases peripheral glucose uptake and decreases hepatic gluconeogenesis.
C. Blocks intestinal absorption of carbohydrates.
D. Enhances insulin sensitivity by reducing free fatty acid levels.
Correct Answer: B. Increases peripheral glucose uptake and decreases hepatic gluconeogenesis.
Rationale: Metformin is a biguanide that primarily reduces hepatic glucose production (gluconeogenesis) and
increases insulin sensitivity in peripheral tissues such as muscle and fat, leading to improved glucose uptake. It
does not stimulate insulin secretion (option A is incorrect). Option C describes alpha-glucosidase inhibitors.
Option D is a secondary effect, not the primary mechanism.
Why Wrong:
A - Metformin does not stimulate insulin secretion; sulfonylureas do.
C - Carbohydrate absorption blockers are acarbose or miglitol, not metformin.
D - While metformin may reduce free fatty acids, its primary action is on hepatic glucose output and
peripheral uptake.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 45: Antidiabetic Agents.
Q3. A nurse is assessing a client who is receiving a continuous intravenous infusion of heparin for a deep vein
thrombosis. Which laboratory value indicates that the heparin therapy is at a therapeutic level?
A. Activated partial thromboplastin time (aPTT) of 45 seconds (control 30 seconds).
B. International normalized ratio (INR) of 2.5.
C. Prothrombin time (PT) of 18 seconds (control 12 seconds).
D. Platelet count of 150,000/mm³.
Correct Answer: A. Activated partial thromboplastin time (aPTT) of 45 seconds (control 30 seconds).
Rationale: Heparin therapy is monitored using the aPTT, with a therapeutic goal typically 1.5 to 2.5 times the
Page 3
Answers (2026/2027 Update) - Chamberlain University
ATI PN Comprehensive Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest NCSBN Guidelines | Graded A+
This comprehensive exam bank contains 250 verified questions and answers designed to prepare
nursing students for the ATI PN (Practical Nurse) exam. Covering all major content areas, this resource
reflects the latest 2026/2027 updates and NCSBN guidelines. Each question includes detailed
rationales and correct answers to enhance understanding and retention. Ideal for Chamberlain
University students seeking a reliable study tool for achieving a high score.
Key Features:
Pharmacological Therapies and Dosage Calculations
Safe and Effective Care Environment (Management, Safety, Infection Control)
Health Promotion and Maintenance (Growth, Development, Prevention)
Psychosocial Integrity (Coping, Mental Health, Therapeutic Communication)
Physiological Integrity (Basic Care, Comfort, Reduction of Risk Potential)
Updates for 2026:
- Updated to reflect 2026/2027 NCSBN PN test plan changes
- Revised rationales for clarity and evidence-based practice
- Added new questions on emerging healthcare topics (e.g., telehealth, COVID-19 management)
- Enhanced distractor explanations to address common misconceptions
Abstract:
The ATI PN Comprehensive Exam Bank is a meticulously curated collection of 250 questions and answers aligned
with the 2026/2027 NCSBN PN test plan. Designed for Chamberlain University nursing students, this resource
covers all core content areas: pharmacological therapies, safe and effective care environment, health promotion,
psychosocial integrity, and physiological integrity. Each question is accompanied by a detailed rationale
explaining the correct answer and why distractors are incorrect, promoting deep learning and critical thinking.
The bank has been updated to include recent healthcare trends and evidence-based practices, ensuring relevance
to current clinical settings. This exam prep tool is ideal for self-assessment, identifying knowledge gaps, and
building confidence for the ATI PN exam. With a focus on high-yield topics and graded A+ standards, it serves as
a comprehensive study guide for achieving exam success.
Keywords:
ATI PN exam, practical nurse, NCLEX-PN, NCSBN, Chamberlain University, exam bank, nursing questions,
rationales
Answer Format:
Each question is followed by the correct answer (marked as 'Correct Answer:') and a detailed rationale explaining
why it is correct. Incorrect options are also explained with distractors to clarify common errors. Rationales are
concise yet comprehensive, referencing evidence-based practice and NCSBN guidelines.
Compliance Checklist:
Aligned with 2026/2027 NCSBN PN test plan
Updated per latest clinical guidelines and evidence-based practice
All questions verified for accuracy by nursing educators
Includes rationales for correct and incorrect answers
Suitable for self-study and exam simulation
Page 1
,Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacological Therapies 1-50 Dosage calculations, medication 20%
administration, adverse effects,
pharmacokinetics
Safe and Effective Care 51-100 Management of care, safety and infection 20%
Environment control, legal/ethical issues, emergency
preparedness
Health Promotion and 101-150 Growth and development, disease 20%
Maintenance prevention, prenatal/postpartum care, health
screening
Psychosocial Integrity 151-200 Coping mechanisms, mental health 20%
disorders, therapeutic communication,
cultural awareness
Physiological Integrity 201-250 Basic care and comfort, reduction of risk 20%
potential, physiological adaptation,
fluid/electrolyte balance
Page 2
, Q1. A client with a history of chronic kidney disease (CKD) stage 4 is admitted with hyperkalemia (serum
potassium 6.8 mEq/L). The provider orders intravenous calcium gluconate, regular insulin with dextrose
50%, and sodium polystyrene sulfonate (Kayexalate). Which of the following best explains the mechanism of
action of the insulin-dextrose combination in this context?
A. Insulin binds to potassium ions, forming an inactive complex that is renally excreted.
B. Insulin stimulates the sodium-potassium ATPase pump, promoting intracellular shift of potassium.
C. Dextrose provides a substrate for insulin to facilitate potassium excretion via the gastrointestinal tract.
D. Insulin increases aldosterone secretion, leading to potassium loss in the urine.
Correct Answer: B. Insulin stimulates the sodium-potassium ATPase pump, promoting intracellular shift of
potassium.
Rationale: Insulin activates the sodium-potassium ATPase pump, which moves potassium from the extracellular
fluid into cells, thereby lowering serum potassium. This effect is rapid and temporary, used in acute hyperkalemia.
Dextrose prevents hypoglycemia caused by insulin. Option A is incorrect because insulin does not bind potassium.
Option C is incorrect because insulin-dextrose does not promote GI excretion. Option D is incorrect because
insulin does not increase aldosterone secretion.
Why Wrong:
A - Insulin does not chemically bind potassium; it facilitates cellular uptake via pump activation.
C - The combination does not enhance GI potassium excretion; that is the role of sodium polystyrene
sulfonate.
D - Insulin has no direct effect on aldosterone; aldosterone increases renal potassium excretion, not cellular
shift.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 50: Agents for Hyperkalemia.
Q2. A client with type 2 diabetes mellitus is prescribed metformin 500 mg twice daily. Which of the following
best describes the primary mechanism by which metformin improves glycemic control?
A. Stimulates pancreatic beta cells to secrete more insulin.
B. Increases peripheral glucose uptake and decreases hepatic gluconeogenesis.
C. Blocks intestinal absorption of carbohydrates.
D. Enhances insulin sensitivity by reducing free fatty acid levels.
Correct Answer: B. Increases peripheral glucose uptake and decreases hepatic gluconeogenesis.
Rationale: Metformin is a biguanide that primarily reduces hepatic glucose production (gluconeogenesis) and
increases insulin sensitivity in peripheral tissues such as muscle and fat, leading to improved glucose uptake. It
does not stimulate insulin secretion (option A is incorrect). Option C describes alpha-glucosidase inhibitors.
Option D is a secondary effect, not the primary mechanism.
Why Wrong:
A - Metformin does not stimulate insulin secretion; sulfonylureas do.
C - Carbohydrate absorption blockers are acarbose or miglitol, not metformin.
D - While metformin may reduce free fatty acids, its primary action is on hepatic glucose output and
peripheral uptake.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 45: Antidiabetic Agents.
Q3. A nurse is assessing a client who is receiving a continuous intravenous infusion of heparin for a deep vein
thrombosis. Which laboratory value indicates that the heparin therapy is at a therapeutic level?
A. Activated partial thromboplastin time (aPTT) of 45 seconds (control 30 seconds).
B. International normalized ratio (INR) of 2.5.
C. Prothrombin time (PT) of 18 seconds (control 12 seconds).
D. Platelet count of 150,000/mm³.
Correct Answer: A. Activated partial thromboplastin time (aPTT) of 45 seconds (control 30 seconds).
Rationale: Heparin therapy is monitored using the aPTT, with a therapeutic goal typically 1.5 to 2.5 times the
Page 3
